Mic Iwashima
Chief Operating Officer chez SATSUMA PHARMACEUTICALS, INC.
Profil
Mic Iwashima is currently the Head of Operations and Vice President at Satsuma Pharmaceuticals, Inc. Prior to this, he attended North Carolina State University for his undergraduate degree.
Postes actifs de Mic Iwashima
| Sociétés | Poste | Début |
|---|---|---|
| SATSUMA PHARMACEUTICALS, INC. | Chief Operating Officer | 01/01/2017 |
Formation de Mic Iwashima
| North Carolina State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Satsuma Pharmaceuticals, Inc.
 Satsuma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It develops novel therapeutic products for the acute treatment of migraines. Its product candidate, STS101, is a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, or DHE, which is designed to be self-administered with a proprietary pre-filled, single-use, nasal delivery device. The company was founded by John Kollins on June 21, 2016 and is headquartered in Durham, NC. | Health Technology |
